The emerging role of the TIM molecules in transplantation

American Journal of Transplantation

Volumn 11, Issue 10, 2011, Pages 2012-2019

  Yeung, M Y ^a   McGrath, M ^a   Najafian, N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Costimulatory molecules; T cell activation; T cell immunoglobulin mucin (TIM) family; transplant immunology

Indexed keywords

MUCIN; T CELL IMMUNOGLOBULIN MUCIN 1; T CELL IMMUNOGLOBULIN MUCIN 3; T CELL IMMUNOGLOBULIN MUCIN 4; UNCLASSIFIED DRUG;

ALLERGY; ALLOIMMUNITY; ASTHMA; AUTOIMMUNITY; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; HUMANS; MICE; MUCINS; TRANSPLANTATION;

EID: 80053317125     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03727.x     Document Type: Review

References (52)

1. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH,. TIM genes: A family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010; 235: 172-189.
2. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV,. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008; 118: 1657-1668. (Pubitemid 351632370)
3. Umetsu SE, Lee WL, McIntire JJ, et al,. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005; 6: 447-454. (Pubitemid 41716757)
4. McIntire JJ, Umetsu SE, Akbari O, et al,. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2: 1109-1116. (Pubitemid 33130144)
5. Meyers JH, Chakravarti S, Schlesinger D, et al,. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol 2005; 6: 455-464. (Pubitemid 41716758)
6. Nakae S, Iikura M, Suto H, et al,. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 2007; 110: 2565-2568. (Pubitemid 47523180)
7. Sizing ID, Bailly V, McCoon P, et al,. Epitope-dependent effect of anti-murine TIM-1 monoclonal antibodies on T cell activity and lung immune responses. J Immunol 2007; 178: 2249-2261. (Pubitemid 46233423)
8. Khademi M, Illes Z, Gielen AW, et al,. T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004; 172: 7169-7176. (Pubitemid 38669161)
9. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK,. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 2005; 11: 362-369. (Pubitemid 41080577)
10. De Souza AJ, Oriss TB, O'Malley KJ, Ray A, Kane LP,. T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation. Proc Natl Acad Sci U S A 2005; 102: 1713-1718.
11. Xiao S, Najafian N, Reddy J, et al,. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med 2007; 204: 1691-1702. (Pubitemid 47048034)
12. Rodriguez-Manzanet R, Meyers JH, Balasubramanian S, et al,. TIM-4 expressed on APCs induces T cell expansion and survival. J Immunol 2008; 180: 4706-4713.
13. De Souza AJ, Oak JS, Jordanhazy R, DeKruyff RH, Fruman DA, Kane LP,. T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase. J Immunol 2008; 180: 6518-6526.
14. Mariat C, Degauque N, Balasubramanian S, et al,. Tim-1 signaling substitutes for conventional signal 1 and requires costimulation to induce T cell proliferation. J Immunol 2009; 182: 1379-1385.
15. Binne LL, Scott ML, Rennert PD,. Human TIM-1 associates with the TCR complex and up-regulates T cell activation signals. J Immunol 2007; 178: 4342-4343.
16. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT,. The costimulatory role of TIM molecules. Immunol Rev 2009; 229: 259-270.
17. Kobayashi N, Karisola P, Pena-Cruz V, et al,. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007; 27: 927-940. (Pubitemid 50014866)
18. Yang PC, Xing Z, Berin CM, et al,. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 2007; 133: 1522-1533. (Pubitemid 350029737)
19. Feng BS, Chen X, He SH, et al,. Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allergy Clin Immunol 2008; 122: 55-61.e7.
20. Mizui M, Shikina T, Arase H, et al,. Bimodal regulation of T cell-mediated immune responses by TIM-4. Int Immunol 2008; 20: 695-708. (Pubitemid 351619237)
21. Zhu C, Anderson AC, Schubart A, et al,. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6: 1245-1252. (Pubitemid 43045636)
22. van de Weyer PS, Muehlfeit M, Klose C, Bonventre JV, Walz G, Kuehn EW,. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun 2006; 351: 571-576. (Pubitemid 44666725)
23. Anderson AC, Anderson DE, Bregoli L, et al,. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007; 318: 1141-1143. (Pubitemid 350134897)
24. Kashio Y, Nakamura K, Abedin MJ, et al,. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 2003; 170: 3631-3636. (Pubitemid 36359232)
25. Seki M, Oomizu S, Sakata KM, et al,. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008; 127: 78-88.
26. Hastings WD, Anderson DE, Kassam N, et al,. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009; 39: 2492-2501.
27. Boenisch O, D'Addio F, Watanabe T, et al,. TIM-3: A novel regulatory molecule of alloimmune activation. J Immunol 2010; 185: 5806-5819
28. Frisancho-Kiss S, Nyland JF, Davis SE, et al,. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006; 176: 6411-6415. (Pubitemid 43787822)
29. Monney L, Sabatos CA, Gaglia JL, et al,. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002; 415: 536-5341.
30. Uchida Y, Ke B, Freitas MC, et al,. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139: 2195-2206.
31. Albacker LA, Karisola P, Chang YJ, et al,. TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells. J Immunol 2010; 185: 6839-6849
32. Nakayama M, Akiba H, Takeda K, et al,. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 2009; 113: 3821-3830.
33. Ueno T, Habicht A, Clarkson MR, et al,. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest 2008; 118: 742-751. (Pubitemid 351206562)
34. Yuan X, Ansari MJ, D'Addio F, et al,. Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci U S A 2009; 106: 10734-10739.
35. Degauque N, Mariat C, Kenny J, et al,. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest 2008; 118: 735-741. (Pubitemid 351206561)
36. Lee HH, Meyer EH, Goya S, et al,. Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. J Immunol 2010; 185: 5225-5235.
37. Ding Q, Yeung M, Camirand G, et al,. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011; [Epub ahead of print].
38. Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK,. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology 2009; 214: 342-349.
39. Sanchez-Fueyo A, Tian J, Picarella D, et al,. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4: 1093-1101. (Pubitemid 37428037)
40. Muthukumarana PA, Zheng XX, Rosengard BR, Strom TB, Metcalfe SM,. In primed allo-tolerance, TIM-3-Ig rapidly suppresses TGFbeta, but has no immediate effect on Foxp3. Transpl Int 2008; 21: 593-597. (Pubitemid 351600069)
41. Sabatos CA, Chakravarti S, Cha E, et al,. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003; 4: 1102-1110. (Pubitemid 37428038)
42. Wang F, He W, Yuan J, et al,. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl Immunol 2008; 19: 12-19.
43. He W, Fang Z, Wang F, et al,. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009; 88: 782-790.
44. Schroppel B, Kruger B, Walsh L, et al,. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol 2010; 21: 536-542
45. Nijboer WN, Schuurs TA, Damman J, et al,. Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation. Am J Transplant 2009; 9: 1752-1759.
46. Hall IE, Yarlagadda SG, Coca SG, et al,. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010; 21: 189-197
47. Zhang J, Gu Y, Xu C, Qu X,. Increased T cell immunoglobulin mucin-3 and its ligand in acquired aplastic anemia. Eur J Haematol 2008; 81: 130-139. (Pubitemid 352019637)
48. van Timmeren MM, Vaidya VS, van Ree RM, et al,. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007; 84: 1625-1630.
49. Szeto CC, Kwan BC, Lai KB, et al,. Urinary expression of kidney injury markers in renal transplant recipients. Clin J Am Soc Nephrol 2010; 5: 2329-2337.
50. Ponciano VC, Renesto PG, Nogueira E, et al,. Tim-3 expression in human kidney allografts. Transpl Immunol 2007; 17: 215-222.
51. Manfro RC, Aquino-Dias EC, Joelsons G, Nogare AL, Carpio VN, Goncalves LF,. Noninvasive Tim-3 messenger RNA evaluation in renal transplant recipients with graft dysfunction. Transplantation 2008; 86: 1869-1874.
52. Renesto PG, Ponciano VC, Cenedeze MA, Saraiva Camara NO, Pacheco-Silva A,. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 2007; 7: 1661-1665. (Pubitemid 46776247)